Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Nov;185(5):429-36.
doi: 10.1016/s1072-7515(97)00088-4.

Hepatic resection and transplantation for peripheral cholangiocarcinoma

F A Casavilla  1 , J W Marsh, S Iwatsuki, S Todo, R G Lee, J R Madariaga, A Pinna, I Dvorchik, J J Fung, T E Starzl
Affiliations

Hepatic resection and transplantation for peripheral cholangiocarcinoma

F A Casavilla et al. J Am Coll Surg. 1997 Nov.

Abstract

Background: Recent publications have questioned the role of orthotopic liver transplantation (OLT) in treating advanced or unresectable peripheral cholangiocarcinoma (Ch-Ca).

Study design: We reviewed our experience with Ch-Ca to determine survival rates, recurrence patterns, and risk factors in 54 patients who underwent either hepatic resection or OLT between 1981 and 1994. Liver transplantation was performed in patients with unresectable tumors (n = 12) and in those with advanced cirrhosis (n = 8). There were 33 women (61%) and 21 men (39%), with a mean age of 54.3 years. The median followup period was 6.8 years. Prognostic risk factors were analyzed by univariate and multivariate analyses.

Results: Mortality within 30 days was 7.4%. Overall patient and tumor-free survival rates were 64% and 57% at 1 year, 34% and 34% at 3 years, and 26% and 27% at 5 years after operation. Thirty-two patients (59.3%) experienced tumor recurrence. Univariate analysis revealed that multiple tumors, bilobar tumor distribution, regional lymph node involvement, presence of metastasis, positive surgical margins, and advanced pTNM stages were significant negative predictors of both tumor-free and patient survival. Multivariate analysis revealed that positive margins, multiple tumors, and lymph node involvement were independently associated with poor prognosis. When patients with these three negative predictors were excluded, the patient survivals at 1, 3, and 5 years were 74%, 64%, and 62%, respectively.

Conclusions: Both hepatic resection and OLT are effective therapies for Ch-Ca when the tumor can be removed with adequate margins, the lesion is singular, and lymph nodes are not involved.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Actuarial (overall) patient and tumor-free survival.
FIG 2
FIG 2
Actuarial patient survival. Hx, hepatic resection; OLT, orthotopic liver transplantation.
FIG 3
FIG 3
Actuarial tumor-free survival. Hx, hepatic resection; OLT, orthotopic liver transplantation.
FIG 4
FIG 4
Patient and tumor-tree survival by TNM stage.
FIG 5
FIG 5
Actuarial patient and tumor-free survival of low- and high-risk groups.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kamiyama Y, Tobe T. Treatment of primary liver cancer in Japan. In: Okuda K, Ishak KG, editors. Neoplasms of the Liver. Tokyo: Springer-Verlag; 1987. pp. 375–380.
    1. Iwatsuki S, Sheahan DG, Starzl TE. The changing face of hepatic resection. Curr Probe Surg. 1989;26:283–379. - PMC - PubMed
    1. Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer. 1989;64:2226–2232. - PubMed
    1. Chu KM, Lai ECS, Al-Hadeedi S, et al. Intrahepatic cholangiocarcinoma. World J Surg. 1997;21:301–306. - PubMed
    1. Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. (in press). - PMC - PubMed